Nicole Keith Email & Phone Number

Seattle, Washington, Us

• Leads a team of professionals responsible for the company's Financial Planning & Analysis, Investor Relations and Corporate Communications functions. Main activities include annual budget, long range planning, business planning, investor relations strategy, company brand development, PR/media outreach and internal communications.

Seattle, Wa, Us

• Designed, built and implemented the corporate investor relations strategy in conjunction with the CFO, including evolving investment thesis.• Served as a principal spokesperson to the investment community, communicating the company’s business model, technology, strategy and operational and financial objectives. Advised management team on shareholder questions and concerns.• Executed crisis management plans and procedures and established an infrastructure to rapidly act as required.• Served as a media liaison, driving media coverage of the company’s story and key initiatives. Partnered with media and third-party influencers to increase awareness until a dedicated resource was onboarded.• Performed all tactical projects, including quarter-end activities, investor targeting and outreach, sell-side management, external reports, partnering with internal teams, corporate presentation development, data collection and investor materials for company financing, event calendar organization, press release distribution, website content management and new hire orientation.• Completed projects related to the Celgene-Juno transaction, including management of shareholder inquires, earnings call support, partner introductions, and knowledge transfer.

Foster City, Ca, Us

• Designed and implemented the corporate investor relations strategy in conjunction with the VP, including evolving investment thesis.• Managed content and logistics for Annual Shareholders Meeting, working with Executives, Legal, Finance, HR and vendors to achieve meeting objectives.• Initiated targeting plan to optimize ongoing investor outreach program and evolving shareholder base, in response to emerging international footprint and dividend program announcement.

South San Francisco, Ca, Us

• Executed projects related to the Amgen-Onyx transaction, including management of shareholder inquires, earnings call support, partner introductions, and knowledge transfer.• Designed and implemented the corporate investor relations strategy in conjunction with the VP, including evolving investment thesis.• Managed IR Associate, responsible for event calendar organization, press release distribution, website content management, presentation maintenance, and technology initiatives. • Performed quarter-end activities, including executive document preparation, script, Q&A development, and key messaging. Managed overall production of teleconferences and analyst meetings.• Managed investor targeting activities and outreach programs, including the active management of investor 1-on-1 meetings, non-deal roadshows, sell-side hosted programs, banking conferences, and industry meetings.• Maintained relationships with financial community, and advised management team on shareholder questions and concerns.• Monitored sell-side activity, including developing analytic tools for analyst models, reviewing notes by covering analysts, as well as pertinent industry and competitive pieces.• Developed externally reported information, including the Annual Report, press releases, and factsheet.• Partnered with Finance, Corporate Communications, Legal, Regulatory, and relevant subject matter experts to create consistent and accurate documents regarding company events.• Performed day-to-day activities, including responding to retail investor and sell-side inquiries, updating corporate presentations, completing special projects, and representing the department on internal teams.

South San Francisco, California, Us

• Performed assignments related to the Genentech-Roche transaction, including strategy, planning, and execution of Executive Committee road show, and coordination and development of 2009 Analyst Meeting finance slides.• Executed ad-hoc projects at the request of the CFO and VP, Investor Relations, including competitive analysis of executive stock ownership, competitive review of quarterly earnings calls, and Q&A documentation for finance-related issues.• Updated the Avastin® section of the corporate briefing book on a quarterly basis for executives that discuss company information with investors, resulting in clear, transparent communication of the business’ key components.• Completed additional tasks, including attendance at medical conferences, assistance with Q&A documentation for press releases, and analysis for targeting program.

South San Francisco, California, Us

• Product Operations (PROP) Finance: Created financial model for PROP executive team to evaluate multi-site manufacturing scenarios, providing cost analysis to optimize production planning to 2020.• General Audit: Performed Sarbanes-Oxley 404 testing cycles for Treasury and Collaborations Finance controls; also executed scoping, testing, and reporting of operational audits, including Investment Policy Compliance, Corporate Goals, and Raw Materials Risk Mitigation.• Corporate Treasury: Assisted with daily cash and investment management of company’s $7B portfolio, including monitoring of financial markets and evaluation of credit ratings; also updated Investment Policy and desk procedures.• Financial Planning & Analysis: Created financial model for Executive Committee and Board of Directors to evaluate 10 scenarios, providing long term revenue and EPS projections for strategic planning.• Avastin Franchise Marketing: Developed the Avastin® in prostate cancer strategy for the senior leadership team, providing market analysis on patient segments, current treatment paradigms, market research, and competition to position the product for potential upcoming launch.

Cambridge, Ma, Us

• Developed an integrated risk management process for a senior level cross-functional team to analyze risk in the supply chain, resulting in a model that considers the operational and financial resources needed to reduce and manage risks.

South San Francisco, California, Us

• Designated purification product expert for the large scale manufacturing of the 2002 TNKase and 2003 Activase campaigns, providing technical expertise for quality investigations and training materials.• Redesigned cGMP documentation, wrote validation protocols, and organized the 200 in-process sample matrix for the Activase purification process in response to FDA 483 observations.• Led cross-functional team assembled to improve the operational robustness of a buffer mixing step in a recovery process unit operation, resulting in zero incidents during the subsequent campaign.• Provided process step technical expertise via performance data analysis, on-the-floor support, and Manufacturing Operations training for the Enbrel® contract manufacturing project.• Co-led cross-functional team of company experts responsible for resolving critical project issues and implementing best practices of centrifuge technology throughout the SSF, Vacaville, and Porriño manufacturing facilities.• Managed college intern to complete lab scale protein characterization project that modeled the effects of process deviations on product quality, resulting data presented at the 2002 American Chemical Society National Meeting.

South San Francisco, California, Us

• Appointed as the technical leader for the cross-functional Activase Implementation Team, a group of department representatives that coordinated and executed activities to achieve campaign success.• Conducted pilot plant scale experiments to optimize centrifuge operating parameters for large scale production of Rituxan®, Avastin®, and Raptiva® in the South San Francisco, Vacaville, and Porriño manufacturing facilities.

Mba, Biotechnology

B.S., Chemical Engineering